Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Leavey

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|January 20, 2006
Extracorporeal membrane oxygenation (ECMO) initiation without intubation in two children with mediastinal malignancyJonathan E Wickiser, Marita Thompson, Patrick J Leavey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Reply to J.-G. Wang et alPatrick J Leavey, Mark D Krailo, Steven G DuBois, et al.
Journal of Pediatric Hematology/Oncology|May 16, 2012
Predictive value of interleukin-5 and monocyte chemotactic protein-1 for bacteremia in children with febrile neutropeniaVictor M Aquino, Carrye Cost, Ana Gomez, et al.
The Journal of Biological Chemistry|July 18, 2002
A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activityPatrick J Leavey, Carolina Gonzalez-Aller, Gail Thurman, et al.
Pediatric Blood & Cancer|January 31, 2004
Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumorsDaniel C Bowers, Victor M Aquino, Patrick J Leavey, et al.
Pediatric Blood & Cancer|May 29, 2008
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology GroupPatrick J Leavey, Leo Mascarenhas, Neyssa Marina, et al.
Oncogene|January 26, 2018
PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcomaJason A Hanna, Matthew R Garcia, Alicia Lardennois, et al.
Nature Communications|January 11, 2020
ASCOT identifies key regulators of neuronal subtype-specific splicingJonathan P Ling, Christopher Wilks, Rone Charles, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing SarcomaJingwei Huang, Ayesha Batool, Zifan Gu, et al.
Cold Spring Harbor Molecular Case Studies|October 25, 2019
Novel <i>PDGFRB</i> rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinibMohammed Hassan, Erin Butler, Raphael Wilson, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|January 20, 2006
Extracorporeal membrane oxygenation (ECMO) initiation without intubation in two children with mediastinal malignancyJonathan E Wickiser, Marita Thompson, Patrick J Leavey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
Reply to J.-G. Wang et alPatrick J Leavey, Mark D Krailo, Steven G DuBois, et al.
Journal of Pediatric Hematology/Oncology|May 16, 2012
Predictive value of interleukin-5 and monocyte chemotactic protein-1 for bacteremia in children with febrile neutropeniaVictor M Aquino, Carrye Cost, Ana Gomez, et al.
The Journal of Biological Chemistry|July 18, 2002
A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activityPatrick J Leavey, Carolina Gonzalez-Aller, Gail Thurman, et al.
Pediatric Blood & Cancer|January 31, 2004
Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumorsDaniel C Bowers, Victor M Aquino, Patrick J Leavey, et al.
Pediatric Blood & Cancer|May 29, 2008
Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology GroupPatrick J Leavey, Leo Mascarenhas, Neyssa Marina, et al.
Oncogene|January 26, 2018
PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcomaJason A Hanna, Matthew R Garcia, Alicia Lardennois, et al.
Nature Communications|January 11, 2020
ASCOT identifies key regulators of neuronal subtype-specific splicingJonathan P Ling, Christopher Wilks, Rone Charles, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing SarcomaJingwei Huang, Ayesha Batool, Zifan Gu, et al.
Cold Spring Harbor Molecular Case Studies|October 25, 2019
Novel <i>PDGFRB</i> rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinibMohammed Hassan, Erin Butler, Raphael Wilson, et al.
Pageof 5